HD4529 — A communication from the Medication-Assisted Treatment (MAT) Commission (see Section 103 of Chapter 208 of the Acts of 2018) submitting a report relative to its findings and recommendations regarding the use of medication-assisted treatment for opioid use disorder in the Commonwealth, methadone, buprenorphine and injectable long-acting naltrexone

HD4529 — A communication from the Medication-Assisted Treatment (MAT) Commission (see Section 103 of Chapter 208 of the Acts of 2018) submitting a report relative to its findings and recommendations regarding the use of medication-assisted treatment for opioid use disorder in the Commonwealth, methadone, buprenorphine and injectable long-acting naltrexone · Informed CitizenryThis bill is a communication from the Medication-Assisted Treatment (MAT) Commission, which was established by the CARE Act to study and provide recommendations regarding the use of medication-assi…Open in Informed Citizenry